{
  "id": "52b2ecd34003448f55000003",
  "type": "yesno",
  "question": "Have mutations in the GARS gene been identified to cause Charcot-Marie-Tooth Disease Type 2D (CMT2D)?",
  "ideal_answer": "Charcot-Marie-Tooth disease type 2D (CMT2D) is caused by missense mutations in the glycyl-tRNA synthetase gene (GARS).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/17035524",
    "http://www.ncbi.nlm.nih.gov/pubmed/20301462",
    "http://www.ncbi.nlm.nih.gov/pubmed/16982418",
    "http://www.ncbi.nlm.nih.gov/pubmed/16014653",
    "http://www.ncbi.nlm.nih.gov/pubmed/20301420",
    "http://www.ncbi.nlm.nih.gov/pubmed/22462675",
    "http://www.ncbi.nlm.nih.gov/pubmed/19412816",
    "http://www.ncbi.nlm.nih.gov/pubmed/17663003",
    "http://www.ncbi.nlm.nih.gov/pubmed/22144914",
    "http://www.ncbi.nlm.nih.gov/pubmed/16769947",
    "http://www.ncbi.nlm.nih.gov/pubmed/23990368"
  ],
  "snippets": [
    {
      "text": "Charcot-Marie-Tooth disease type 2D is a hereditary axonal and glycyl-tRNA synthetase (GARS)-associated neuropathy that is caused by a mutation in GARS. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990368",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Mutations in the GARS gene cause Charcot-Marie-Tooth 2D and distal spinal muscular atrophy type V - allelic disorders characterized by predominantly distal upper extremity weakness and atrophy, typically beginning during the second decade of life. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22462675",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Charcot-Marie-Tooth disease type 2D (CMT2D) is a dominantly inherited peripheral neuropathy caused by missense mutations in the glycyl-tRNA synthetase gene (GARS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22144914",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The 13 genes known to be associated with the CMT2 subtypes are KIF1B (CMT2A1), MFN2 (CMT2A2), RAB7A (formerly RAB7) (CMT2B), LMNA (CMT2B1), MED25 (CMT2B2), TRPV4 (CMTC), GARS (CMT2D), NEFL (CMT2E/1F), HSPB1 (CMT2F), MPZ (CMT2I/J), GDAP1 (CMT2H/K), HSPB8 (CMT2L), and AARS (CMT2N). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20301462",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " The diagnosis of GARS-associated axonal neuropathy is based on clinical findings, electromyography (EMG), and molecular genetic testing of GARS, encoding glycyl-tRNA synthetase.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20301420",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Sporadic juvenile muscular atrophy of the distal upper extremity or Hirayama's disease (HD) and autosomal dominant motor distal neuronopathy/axonopathy (CMT2D/dSMA-V), produced by glycyl-tRNA synthetase (GARS) gene mutations, share some clinical features including: young age of onset, predilection for the distal upper extremity, asymmetry, sparing of proximal muscles and unusual cold sensitivity. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19412816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Distal hereditary motor neuropathy type V (dHMN-V) and Charcot-Marie-Tooth syndrome (CMT) type 2 presenting with predominant hand involvement, also known as CMT2D and Silver syndrome (SS) are rare phenotypically overlapping diseases which can be caused by mutations in the Berardinelli-Seip Congenital Lipodystrophy 2 (BSCL2) and in the glycyl-tRNA synthetase encoding (GARS) genes. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17663003",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We previously implicated mutations in the gene encoding glycyl-tRNA synthetase (GARS) as the cause of CMT2D and dSMA-V.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17035524",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Of the many inherited Charcot-Marie-Tooth peripheral neuropathies, type 2D (CMT2D) is caused by dominant point mutations in the gene GARS, encoding glycyl tRNA synthetase (GlyRS). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16982418",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Missense mutations in the glycyl-tRNA synthetase (GARS) gene have been recently reported in families with either dHMN-V, CMT2D, or both.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16769947",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Based on the presence or absence of sensory changes, the disease phenotype was initially defined as distal spinal muscular atrophy type V (dSMA-V) in three families, Charcot-Marie-Tooth disease type 2D (CMT2D) in a single family, and as either dSMA-V or CMT2D in patients of another large family. Linkage to chromosome 7p15 and the presence of disease-associated heterozygous GARS mutations have been identified in patients from each of the five studied families. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16014653",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.uniprot.org/uniprot/SYG_RAT",
    "http://www.uniprot.org/uniprot/SYG_HUMAN",
    "http://www.uniprot.org/uniprot/SYG_PONAB"
  ],
  "exact_answer": "Yes"
}